Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Lake Shore Bancorp
LSBK
$135M
| $694K | ﹤0.01% |
45,709
+650
| +1% | +$9.93K |
|
2902
Neumora Therapeutics
NMRA
$276M
| $692K | ﹤0.01% |
354,850
+247,600
| +231% | +$642K |
|
2903
CuriosityStream
CURI
$139M
| $690K | ﹤0.01% |
233,340
+125,794
| +117% | +$425K |
|
2904
LGL Group
LGL
$44.3M
| $690K | ﹤0.01% |
99,240
| – | – |
|
2905
Bank Of The James
BOTJ
$122M
| $689K | ﹤0.01% |
33,458
+731
| +2% | +$14.5K |
|
|
NEXN
2906
Nexxen International
NEXN
$547M
| $687K | ﹤0.01% |
105,365
-5,885
| -5% | -$37.6K |
|
2907
United Bancorp
UBCP
$94.3M
| $687K | ﹤0.01% |
45,156
| – | – |
|
2908
Hanover Bancorp
HNVR
$179M
| $683K | ﹤0.01% |
31,643
+554
| +2% | +$12.3K |
|
2909
Ramaco Resources Class B
METCB
$475M
| $681K | ﹤0.01% |
67,614
+4,585
| +7% | +$55.4K |
|
2910
Kyverna Therapeutics
KYTX
$450M
| $677K | ﹤0.01% |
78,419
+6
| +0% | +$50 |
|
2911
Canterbury Park Holding Corp
CPHC
$80.1M
| $666K | ﹤0.01% |
43,225
| – | – |
|
2912
Protalix BioTherapeutics
PLX
$191M
| $644K | ﹤0.01% |
296,843
+268,099
| +933% | +$665K |
|
|
SY
2913
So-Young International
SY
$194M
| $638K | ﹤0.01% |
233,536
+54,122
| +30% | +$162K |
|
2914
Zentalis Pharmaceuticals
ZNTL
$308M
| $634K | ﹤0.01% |
272,034
+175,771
| +183% | +$454K |
|
2915
The GEO Group
GEO
$4.13B
| $633K | ﹤0.01% |
37,652
-41,764
| -53% | -$663K |
|
2916
Cognyte Software
CGNT
$612M
| $622K | ﹤0.01% |
76,792
| – | – |
|
|
PKST
2917
DELISTED
Peakstone Realty Trust
PKST
| $620K | ﹤0.01% |
29,666
-194,104
| -87% | -$3.63M |
|
2918
CPI Card Group
PMTS
$224M
| $619K | ﹤0.01% |
42,651
-2,876
| -6% | -$38.9K |
|
2919
Mercado Libre
MELI
$91.3B
| $614K | ﹤0.01% |
355
+25
| +8% | +$48.2K |
|
2920
Alpha Pro Tech
APT
$50.4M
| $610K | ﹤0.01% |
137,335
| – | – |
|
2921
Alector
ALEC
$164M
| $610K | ﹤0.01% |
283,817
+84,691
| +43% | +$170K |
|
2922
Avalo Therapeutics
AVTX
$976M
| $607K | ﹤0.01% |
+40,821
| New | +$638K |
|
2923
Broadwind
BWEN
$113M
| $607K | ﹤0.01% |
291,801
+26,546
| +10% | +$72K |
|
|
VG
2924
Venture Global Inc
VG
$35.6B
| $606K | ﹤0.01% |
+38,445
| New | +$412K |
|
2925
Hain Celestial
HAIN
$47.8M
| $603K | ﹤0.01% |
864,353
-276,798
| -24% | -$257K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.